欧洲迷幻药市场 – 行业趋势及 2029 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Pharmaceutical Europe Psychedelic Drugs Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲迷幻药市场 – 行业趋势及 2029 年预测

  • Pharmaceutical
  • Published Report
  • Jun 2022
  • Europe
  • 350 页面
  • 桌子數： 155
  • 图号： 52
立即购买 立即购买

Europe Psychedelic Drugs Market

市场规模（十亿美元）

CAGR :  % Diagram

Diagram Forecast Period
 2022 –2029
Diagram Market Size (Base Year)
 USD 235.71 Million
Diagram Market Size (Forecast Year)
 USD 607.39 Million
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

>欧洲迷幻药市场，按来源（合成和天然）、类型（致幻剂、解离剂和其他）、药物（γ-羟基丁酸、氯胺酮、裸盖菇素等）、应用（发作性睡病、难治性抑郁症、重度抑郁症、阿片类药物成瘾、创伤后应激障碍等）、给药途径（口服、吸入、注射）、最终用户（医院、专科诊所、家庭护理、其他）、分销渠道（医院药房、零售药房、网上药房）划分，行业趋势及预测至 2029 年

欧洲迷幻药市场

欧洲迷幻药市场分析与洞察

迷幻药涉及多种化学物质，包括麦角酸二乙酰胺 (LSD) 和从植物中提取的化学物质。这些药物能够改变或增强感官知觉、思维过程、能量水平，据报道还能促进精神体验。

欧洲迷幻药市场

迷幻药可分为共情药和解离药（如苯基环己基哌啶 (PCP)）和血清素药（经典致幻剂），如 LSD。这两种迷幻药都会引起幻觉和感觉，此外，解离药会使人失去对自己身体或环境的控制，使他们感到与世隔绝。根据来源，迷幻药分为天然和合成两种。

这些药物广泛应用于治疗重度抑郁症、创伤后应激障碍、惊恐障碍、难治性抑郁症和阿片类药物成瘾等。迷幻药还有其他几个名字，例如麦角酸衍生物 (LSD) 也被称为吸墨纸、点、糖、酸、旅行和窗格，氯胺酮也被称为维生素 K、肿块、绿色、K/特殊 K、紫色和超酸，PCP 也被称为天使/天使尘、船/爱之船、和平、杀手杂草、超级草和臭氧。

欧洲迷幻药市场预计将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，该市场将以 12.7% 的复合年增长率增长，预计将从 2021 年的 2.3571 亿美元达到 2029 年的 6.0739 亿美元。

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020 (可定制至 2019-2014)

定量单位

收入（百万美元），定价（美元）

涵盖的领域

按来源（合成和天然）、类型（共情剂、解离剂和其他）、药物（γ-羟基丁酸、氯胺酮、裸盖菇素等）、用途（发作性睡病、难治性抑郁症、重度抑郁症、阿片类药物成瘾、创伤后应激障碍等）、给药途径（口服、吸入、注射）、最终用户（医院、专科诊所、家庭护理、其他）、分销渠道（医院药房、零售药房、网上药房）

覆盖国家

英国、德国、意大利、法国、西班牙、俄罗斯、波兰、荷兰、匈牙利、奥地利、挪威、瑞士、爱尔兰、比利时、立陶宛和欧洲其他国家

涵盖的市场参与者

在市场上交易的主要公司包括 Jazz Pharmaceuticals, Inc.、Janssen Global Services, LLC（Johnson & Johnson Services, Inc. 的子公司）、Hikma Pharmaceuticals PLC、COMPASS、Verrian、Pfizer Inc.、F. Hoffmann-La Roche Ltd、Avadel、Celon Pharma SA.、Cybin Corp.、GH Research、Entheon Biomedical Corp 等

市场定义

迷幻药涉及多种化学物质，包括麦角酸二乙酰胺 (LSD) 和从植物中提取的化学物质。这些药物能够改变或增强感官知觉、思维过程、能量水平，据报道还能促进精神体验。

迷幻药可分为共情药和解离药（如苯基环己基哌啶 (PCP)）和血清素药（经典致幻剂），如 LSD。这两种迷幻药都会引起幻觉和感觉，此外，解离药会使人失去对自己身体或环境的控制，使他们感到与世隔绝。根据来源，迷幻药分为天然和合成两种。

这些药物广泛应用于治疗重度抑郁症、创伤后应激障碍、惊恐障碍、难治性抑郁症和阿片类药物成瘾等。迷幻药还有其他几个名字，例如麦角酸衍生物 (LSD)，也称为吸墨纸、点、糖、酸、旅行和窗格，氯胺酮也称为维生素 K、肿块、绿色、K/特殊 K、紫色和超酸，PCP 也称为天使/天使尘、船/爱之船、和平、杀手杂草、超级草和臭氧。

迷幻药市场动态

驱动程序

  • 越来越多的人接受迷幻药治疗抑郁症

迷幻药在过去十年中大受欢迎，因为它与人类的精神康复和治疗实践密切相关，具有治愈心灵的力量。越来越多的研究人员和科学家正在探索迷幻药的治疗价值和化合物，这些化合物可能成为抑郁症患者的新治疗选择。迷幻药的持续研究和开发提高了迷幻药的接受度。迷幻药的良好效果增加了英国和其他地区的迷幻药使用量，从而导致对迷幻药的需求增加，因此这些因素有望成为市场增长的驱动力。

  • 抑郁症和精神障碍患病率不断上升

精神障碍（或心理疾病）会影响人们的感觉、情绪、思维和行为，可能是长期的（慢性的）或偶尔的。抑郁症和精神障碍会影响个人执行日常任务的能力。精神障碍有很多不同的类型。由于各种因素，包括家族史和基因、虐待或压力、生物因素、饮酒或消遣性药物的使用等，抑郁症和精神障碍在全球范围内有所增加。

此外，非法物质消费的增加也增加了抑郁症和精神障碍的发病率。因此，抑郁症和精神障碍的患病率不断上升，增加了对迷幻药的需求，而迷幻药有望成为市场增长的驱动力。

欧洲迷幻药市场

机会

  • 增加迷幻药的研发活动

数千年来，迷幻植物和真菌一直被用于本土医药传统。1938 年，阿尔伯特·霍夫曼发起了新型迷幻药开发研究。他合成了第一种麦角酸二乙酰胺 (LSD-25)，五年后被公认为第一个服用 LSD 的人。霍夫曼当时并不知道该产品的重大影响和作用。在 20 世纪 50 年代和 60 年代文化和科学探索不断增长的时期之后，迷幻药开发研究几乎停滞不前。增加迷幻药研发支出正在为市场创造新的机会。因此，增加迷幻药研发活动是市场增长的机会。

此外，主要市场参与者采取的战略举措将为 2022-2029 年预测期内的迷幻药市场提供结构完整性和未来机会。

克制/挑战

  • 迷幻药价格高昂

然而，迷幻药的高成本将阻碍迷幻药市场的增长率。此外，在上述预测期内，严格的规则和法规将进一步挑战市场。

这份迷幻药市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需获取有关迷幻药市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。

新冠肺炎疫情对迷幻药市场的影响

COVID-19 对市场产生了积极影响。疫情期间的封锁和隔离使疾病管理和药物依从性变得复杂。因此，世界人口中各种治疗药物的使用量大幅增加。因此，疫情对这个市场产生了积极影响。

近期发展

  • 2020 年 8 月，杨森制药公司获批其 Spravato 鼻喷雾剂用于治疗有自杀倾向的人。由于大约 11% 至 12% 的美国人患有导致他们自杀的重度抑郁症，这项批准为这些患者提供了一种卓越的治疗方法，并为公司创造更多收入铺平了道路。

欧洲迷幻药市场范围

欧洲迷幻药市场分为来源、类型、药物、应用、给药途径、最终用户和分销渠道。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。

来源

  • 合成的
  • 自然的

根据来源，欧洲迷幻药市场分为合成迷幻药和天然迷幻药。

类型

  • 共情因素
  • 解离性药物
  • 其他的

根据类型，欧洲迷幻药市场分为共情剂、分离剂和其他类。

药物

  • γ-羟基丁酸
  • 氯胺酮
  • 裸盖菇素
  • 其他的

根据药物类型，欧洲迷幻药市场分为γ-羟基丁酸、氯胺酮、裸盖菇素和其他药物。

..应用

  • 嗜睡症，
  • 难治性抑郁症
  • 重度抑郁症
  • 鸦片成瘾
  • 创伤后应激障碍
  • 其他的

根据应用，欧洲迷幻药市场分为发作性睡病、难治性抑郁症、重度抑郁症、阿片类药物成瘾、创伤后应激障碍等。

给药途径

  • 口服
  • 吸入
  • 注射剂

根据给药途径，欧洲迷幻药市场分为口服、吸入和注射。

最终用户

  • 医院
  • 专科诊所
  • 家庭护理
  • 其他的

根据最终用户，欧洲迷幻药市场分为医院、专科诊所、家庭护理和其他。

分销渠道

  • 医院药房
  • 零售药店
  • 网上药店

欧洲迷幻药市场

根据分销渠道，欧洲迷幻药市场分为医院药房、零售药房和网上药房。

迷幻药市场区域分析/见解            

对迷幻药市场进行了分析，并按国家、来源、类型、药物、应用、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势。

迷幻药报告涉及的国家包括英国、德国、意大利、法国、西班牙、俄罗斯、波兰、荷兰、匈牙利、奥地利、挪威、瑞士、爱尔兰、比利时、立陶宛和欧洲其他地区。

德国是欧洲地区在迷幻药市场中市场份额和市场收入占主导地位的国家，并将在预测期内继续保持主导地位。这是由于该地区对精神障碍的认识很高，而且快速的研究发展正在推动市场的发展。

报告的国家部分还提供了影响单个市场因素和市场法规变化的信息，这些因素和变化会影响市场的当前和未来趋势。新旧销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测单个国家市场情况的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因本土和国内品牌的激烈竞争而面临的挑战以及销售渠道的影响。

竞争格局和迷幻市场份额分析

迷幻药市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对迷幻药市场的关注有关。

迷幻药市场的一些主要参与者包括 Jazz Pharmaceuticals, Inc.、Janssen Global Services, LLC（Johnson & Johnson Services, Inc. 的子公司）、Hikma Pharmaceuticals PLC、COMPASS、Verrian、Pfizer Inc.、F. Hoffmann-La Roche Ltd、Avadel、Celon Pharma SA.、Cybin Corp.、GH Research、Entheon Biomedical Corp 等。

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、欧洲与地区和供应商份额分析。如有进一步询问，请要求分析师致电。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们很自豪能够为现有和新客户提供符合其目标的数据和分析。报告可以定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家名单）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE Psychedelic drugs MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type of Psychedelic drugs LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET APPLICATION COVERAGE GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
  5. epidemiology
  6. REGULATORY FRAMEWORK: EUROPE PSYCHEDELIC DRUGS MARKET
    1. REGULATORY SCENARIO IN INDIA
    2. REGULATORY SCENARIO IN UAE
    3. REGULATORY SCENARIO IN AFRICA
    4. REGULATORY SCENARIO IN THE U.S.
    5. REGULATORY SCENARIO IN BRAZIL
    6. REGULATORY SCENARIO IN THE U.K.
  7. Pipeline analysis
  8. market overview
    1. DRIVERS
      1. GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS FOR TREATING DEPRESSION
      2. INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS
      3. RISING AWARENESS TOWARDS MENTAL HEALTH
      4. ONGOING CLINICAL TRIALS
      5. RISE IN PRODUCT APPROVALS
    2. RESTRAINTS
      1. STRINGENT REGULATIONS FOR PSYCHEDELIC DRUGS
      2. HIGH COST OF PSYCHEDELIC DRUGS
      3. PATENT EXPIRY OF PSYCHEDELIC DRUGS
    3. OPPORTUNITIES
      1. INCREASING R&D ACTIVITIES IN PSYCHEDELIC DRUGS
      2. BREAKTHROUGH THERAPY DESIGNATION BY REGULATORY AUTHORITY
      3. UPCOMING REHABILITATION CENTERS
      4. AVAILABILITY OF CERTIFIED HEALTHCARE PROFESSIONALS
    4. CHALLENGES
      1. SIDE EFFECTS ASSOCIATED WITH PSYCHEDELIC DRUGS
      2. RISE IN ALTERNATIVES
      3. OTHER TREATMENT OPTIONS
  9. COVID-19 IMPACT ON EUROPE PSYCHEDELIC DRUGS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS FOR MANUFACTURERS
    5. CONCLUSION
  10. Europe psychedelic drug market, BY source
    1. overview
    2. SYNTHETIC
    3. natural
  11. Europe psychedelic drugs MARKET, BY type
    1. overview
    2. empathogens
    3. dissociatives
    4. others
  12. Europe psychedelic drugs MARKET, BY drugs
    1. overview
    2. gamma-hydroxybutyric acid
    3. ketamine
    4. psilocybin
    5. others
  13. Europe psychedelic drugs MARKET, BY appplication
    1. overview
    2. narcolepsy
    3. Treatment resistant depression
    4. major depressive disorder
    5. opiate addiction
    6. post-traumatic stress disorder
    7. others
  14. Europe psychedelic drug market, BY route of administration
    1. overview
    2. oral
    3. inhalation
    4. injectable
  15. Europe psychedelic drugs MARKET, BY end user
    1. overview
    2. hospitals
    3. Specialty Clinics
    4. Homecare
    5. others
  16. Europe psychedelic drugs MARKET, BY distribution channel
    1. overview
    2. Hospital Pharmacy
    3. retail Pharmacy
    4. online Pharmacy
  17. EUROPE Psychedelic Drugs MARKET, BY region
    1. EUROPE
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. SPAIN
      6. Russia
      7. Poland
      8. Switzerland
      9. Netherlands
      10. Hungary
      11. Austria
      12. Norway
      13. Ireland
      14. Belgium
      15. Lithuania
      16. rest of europe
  18. Europe Psychedelic drugs market: COMPANY landscape
    1. company share analysis: Europe
  19. swot
  20. company profile
    1. JAZZ PHARMACEUTICALS, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. JANSSEN PHARMACEUTICALS, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Pfizer Inc.
      1. REVENUE ANALYSIS
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. VERRIAN
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    5. AVADEL
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. RECENT DEVELOPMENTS
    6. Celon Pharma S.A.
      1. COMPANY SNAPSHOT
      2. PIPELINE PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. COMPASS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    9. HIKMA PHARMACEUTICALS PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. neuroRX, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. PHARMATHER INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. usonainstitute.org
      1. INSTITUTE SNAPSHOT
      2. PIPELINE PORTFOLIO
      3. RECENT DEVELOPMENTS
  21. questionnaire
  22. related reports

表格列表

TABLE 1 U.S. psychedelic drugs market, company wise pipeline analysis

TABLE 2 U.S. psychedelic drugs market, Research Institute pipeline analysis

TABLE 3 Psychedelics researches, in Europe

TABLE 4 Mental Illness in the U.S. adults, in 2018

TABLE 5 Mental Disorders, in the U.S. adults, in 2018

TABLE 6 More than one in six people in EU countries have a mental health problem

TABLE 7 Men are more likely to die from suicide, in all EU countries

TABLE 8 Mental Disorders causeD by usage of substance disorders, in world, in 2017

TABLE 9 Drug Development Pathway for FDA approval of New Medications

TABLE 10 The 1971 UN Convention on Psychotropic Substances

TABLE 11 cost of psychedelic drugs

TABLE 12 Total costs (direct and indirect) of mental health problems in EU countries, in million and as a share of GDP, In 2015

TABLE 13 psychedelic drugs R&D activities

TABLE 14 Europe Psychedelic drug market, By source 2020-2028 (USD Million)

TABLE 15 Europe Synthetic in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 16 Europe Natural in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 17 Europe psychedelic drug market, By Type, 2020-2028 (USD Million)

TABLE 18 Europe Empathogens in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 19 Europe Dissociatives in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 20 Europe Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 21 Europe Therapy in Psychedelic Drugs Market, By Drugs, 2019-2028 (USD Million)

TABLE 22 Europe Gamma-Hydroxybutyric Acid in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 23 Europe Ketamine in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 24 Europe Psilocybin in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 25 Europe Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 26 Europe application in psychedelic drugs Market, By Application, 2019-2028 (USD Million)

TABLE 27 Europe Narcolepsy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 28 Europe Treatment Resistant Depression in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 29 Europe Major Depressive Disorder in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 30 Europe Opiate Addiction in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 31 Europe Post-Traumatic Stress Disorder in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 32 Europe Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 33 Europe Psychedelic Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 34 Europe Oral in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 35 Europe Inhalation in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 36 Europe Injectable in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 37 Europe psychedelic drug market, By END USER, 2020-2028 (USD Million)

TABLE 38 Europe Hospitals in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 39 Europe Specialty Clinics in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 40 Europe Homecare in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 41 Europe Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 42 Europe medication & supplements in psychedelic drug market, By distribution channel, 2020-2028 (USD million)

TABLE 43 Europe Hopitals Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 44 Europe Retail Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 45 Europe Online Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 46 EUROPE PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 47 EUROPE PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 48 EUROPE PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 49 EUROPE PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 50 EUROPE PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 51 EUROPE PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 52 EUROPE PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 53 EUROPE PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 54 Germany PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 55 Germany PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 56 Germany PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 57 Germany PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 58 Germany PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 59 Germany PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 60 Germany PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 61 U.K. PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 62 U.K. PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 63 U.K. PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 64 U.K. PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 65 U.K. PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 66 U.K. PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 67 U.K. PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 68 France PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 69 France PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 70 France PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 71 France PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 72 France PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 73 France PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 74 France PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 75 Italy PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 76 Italy PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 77 Italy PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 78 Italy PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 79 Italy PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 80 Italy PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 81 Italy PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 82 spain PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 83 Spain PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 84 Spain PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 85 Spain PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 86 Spain PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 87 Spain PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 88 Spain PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 89 RUSSIA PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 90 Russia PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 91 Russia PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 92 Russia PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 93 Russia PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 94 Russia PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 95 Russia PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 96 Poland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 97 Poland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 98 Poland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 99 Poland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 100 Poland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 101 Poland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 102 Poland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 103 Switzerland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 104 Switzerland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 105 Switzerland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 106 Switzerland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 107 Switzerland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 108 Switzerland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 109 Switzerland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 110 Netherlands PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 111 Netherlands PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 112 Netherlands PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 113 Netherlands PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 114 Netherlands PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 115 Netherlands PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 116 Netherlands PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 117 Hungary PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 118 Hungary PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 119 Hungary PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 120 Hungary PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 121 Hungary PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 122 Hungary PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 123 Hungary PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 124 Austria PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 125 Austria PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 126 Austria PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 127 Austria PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 128 Austria PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 129 Austria PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 130 Austria PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 131 Norway PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 132 Norway PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 133 Norway PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 134 Norway PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 135 Norway PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 136 Norway PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 137 Norway PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 138 Ireland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 139 Ireland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 140 Ireland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 141 Ireland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 142 Ireland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 143 Ireland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 144 Ireland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 145 Belgium PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 146 Belgium PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 147 Belgium PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 148 Belgium PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 149 Belgium PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 150 Belgium PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 151 Belgium PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 152 Lithuania PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 153 Lithuania PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 154 Lithuania PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 155 Lithuania PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 156 Lithuania PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 157 Lithuania PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 158 Lithuania PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 159 rest of europe PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

图片列表

FIGURE 1 Europe PSYCHEDELIC DRUGS MARKET: SEGMENTATION

FIGURE 2 EUROPE PSYCHEDELIC DRUGS MARKET : DATA TRIANGULATION

FIGURE 3 Europe Psychedelic drugs Market: DROC ANALYSIS

FIGURE 4 Europe Psychedelic drugs market: Europe VS REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Psychedelic drugs Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Psychedelic drugs MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Psychedelic drugs MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE PSYCHEDELIC DRUGS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE psychedelic drugs Market: MARKET APPLICATION COVERAGE GRID

FIGURE 10 EUROPE PSYCHEDELIC DRUGS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 Europe Psychedelic drugs market: SEGMENTATION

FIGURE 12 GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS FOR TREATING DEPRESSION AND INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS are DRIVing THE Europe Psychedelic drugs MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 SYNTHETIC SEGMENT is expected to account for the largest share of the Europe PSYCHEDELIC DRUGS MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE PSYCHEDELIC DRUGS MARKET

FIGURE 15 MENTAL ILLNESS AMONG THE U.S. ADULTS, IN 2018, BY DEMOGRAPHIC GROUP

FIGURE 16 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2018, BY DEMOGRAPHIC GROUP

FIGURE 17 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2018, BY GENDER

FIGURE 18 PREVALENCE OF MENTAL HEALTH DISORDERS BY DISORDER TYPE, IN WORLD, IN 2017

FIGURE 19 MAGIC MUSHROOMS PRICES FOR RESEARCHERS, IN THE U.S.

FIGURE 20 Europe psychedelic drugs market: BY source, 2020

FIGURE 21 Europe psychedelic drugs market: BY source, 2021-2028 (USD Million)

FIGURE 22 Europe psychedelic drugs market: BY source, CAGR (2021-2028)

FIGURE 23 Europe psychedelic drugs market: BY source, LIFELINE CURVE

FIGURE 24 Europe psychedelic drugs market: BY type, 2020

FIGURE 25 Europe psychedelic drugs market: BY type, 2021-2028 (USD Million)

FIGURE 26 Europe psychedelic drugs market: BY type, CAGR (2021-2028)

FIGURE 27 Europe psychedelic drugs market: BY type, LIFELINE CURVE

FIGURE 28 Europe psychedelic drugs market: BY drugs, 2020

FIGURE 29 Europe psychedelic drugs market: BY drugs, 2021-2028 (USD Million)

FIGURE 30 Europe psychedelic drugs market: BY drugs, CAGR (2021-2028)

FIGURE 31 Europe psychedelic drugs market: BY drugs, LIFELINE CURVE

FIGURE 32 Europe psychedelic drugs market: BY application, 2020

FIGURE 33 Europe psychedelic drugs market: BY application, 2021-2028 (USD Million)

FIGURE 34 Europe psychedelic drugs market: BY applicaiton, CAGR (2021-2028)

FIGURE 35 Europe psychedelic drugs market: BY application, LIFELINE CURVE

FIGURE 36 Europe psychedelic drug market: BY route of administraiton, 2020

FIGURE 37 Europe psychedelic drug market: BY route of administration, 2020-2028 (USD Million)

FIGURE 38 Europe psychedelic drug market: BY route of administration, CAGR (2020-2028)

FIGURE 39 Europe psychedelic drug market: BY route of administration, LIFELINE CURVE

FIGURE 40 Europe psychedelic drug market: BY end user, 2020

FIGURE 41 Europe psychedelic drug market: BY end user, 2020-2028 (USD Million)

FIGURE 42 Europe psychedelic drug market: BY end user, CAGR (2020-2028)

FIGURE 43 Europe psychedelic drug market: BY end user, LIFELINE CURVE

FIGURE 44 Europe psychedelic drugs market: BY distribution channel, 2020

FIGURE 45 Europe psychedelic drugs market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 46 Europe psychedelic drugs market: BY distribution channel, CAGR (2020-2028)

FIGURE 47 Europe psychedelic drugs market: BY distribution channel, LIFELINE CURVE

FIGURE 48 EUROPE PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2020)

FIGURE 49 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020)

FIGURE 50 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 51 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 52 EUROPE PSYCHEDELIC DRUGS MARKET: BY SOURCE (2021-2028)

FIGURE 53 Europe Psychedelic drugs market: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The significant factors flourishing the growth of the Europe Psychedelic Drugs Market are Growing Acceptance of Psychedelic Drugs for Treating Depression and Increasing Prevalence of Depression and Mental Disorders.
The major players operating in the Europe Psychedelic Drugs Market are Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.) (Belgium), Hikma Pharmaceuticals PLC (U.K.), COMPASS (U.K.), Verrian (Germany), Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Jazz Pharmaceuticals, Inc. (Ireland), Avadel (Ireland), Celon Pharma S.A. (Poland), NeuroRx, Inc. (U.S.), Mind Medicine Inc (U.S.).
On the basis of application, the Europe Psychedelic Drugs Market is segmented into Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder & Others.
The market value for Europe Psychedelic Drugs Market is expected USD 607.39 million by 2029.

浏览相关页面

Banner